其他
PD-1/PD-L1抑制剂在人体组织内分布如何?
2. Bensch F, van der Veen EL, Lub-de Hooge MN, etal. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinicalresponse to PD-L1 blockade in cancer. Nat Med. 2018;24(12):1852-1858.doi:10.1038/s41591-018-0255-83. P1.04-12 Tumor Uptake and Biodistribution of89Zr-Labeled Pembrolizumab in Patients with Metastatic Non-Small-Cell LungCancer .Journal of Thoracic Oncology 14(10):S443 ·October 20194. J Nucl Med May 1, 2020 vol. 61 no. supplement 13475. 李丹, 程思源, 朱小华. 靶向PD-1/PD-L1通路的肿瘤分子显像研究进展 [J]. 中华核医学与分子影像杂志,2017,37(12 ): 809-814. DOI: 10.3760/cma.j.issn.2095-2848.2017.12.0156. 王淑静, 徐晓霞, 周欣, 刘特立, 李囡, 朱华, 杨志. 肿瘤免疫治疗PD-1/PD-L1靶向核素分子探针的研究进展[J]. 肿瘤防治研究,2020, 47(01): 70-76.https://mp.weixin.qq.com/s/vfQCoPOVEKFrcKoDJq58
精彩推荐:
- End -